Mental Health News and Research

Latest Mental Health News and Research

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.

7 Oct 2009

Cognitive behavioral therapy effective for bulimia and binge eating disorders

Although most people with bulimia and binge eating disorders wait many years before seeking help, a new review shows that psychological treatment can make a large difference — and that cognitive behavioral therapy (CBT) is the most effective talk therapy for these disorders.

6 Oct 2009

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.

6 Oct 2009

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL (“Biovail”), a subsidiary of Biovail Corporation.

6 Oct 2009

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded a $6.3 million contract by the National Institute of Mental Health (NIMH) to conduct preclinical safety studies of promising novel ligands that will be used for brain imaging research and clinical applications.

6 Oct 2009

Telephone program to mange depression offers significant benefits at moderate increase in costs: Study

Patients who participate in a structured telephone program to manage their depression appear to experience significant benefits and only a moderate increase in health care costs when compared with those who receive usual care, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Oct 2009

Individuals who follow the Mediterranean dietary pattern at reduced risk to develop depression: Study

Individuals who follow the Mediterranean dietary pattern—rich in vegetables, fruits, nuts, whole grains and fish—appear less likely to develop depression, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Oct 2009

Group Health Research Institute to receive federal stimulus funds from ARRA

Group Health Research Institute, formerly Group Health Center for Health Studies, will receive more than $15 million in federal stimulus funding from ARRA, the American Recovery and Reinvestment Act of 2009.

6 Oct 2009

NIH awards Galenea a Challenge Grant for developing predictive in vivo models of cognition

Galenea Corp., a fully-integrated CNS drug discovery company, announced today that it has been awarded an NIH Challenge Grant in Health and Science Research (RC1) as part of the American Recovery and Reinvestment Act of 2009 (Recovery Act). This two-year grant from the National Institute of Mental Health addresses the specific topic of "Screening Approaches to Identify Pharmacologic Treatments for Mental Disorders" within the challenge area of Translational Science.

6 Oct 2009

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

Pico-Tesla commences Phase III clinical trial its Resonator system for treating Parkinson’s disease

Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has commenced a Phase III clinical trial of its patented Resonator™ system that facilitates the Company’s proprietary magnetic (Magneceutical™) therapy for treating Parkinson’s disease patients.

6 Oct 2009

Butler Hospital leads clinical study for effectiveness and safety of DBS for OCD

Butler Hospital in Providence, R.I., is leading a clinical study evaluating the effectiveness and safety of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD).

6 Oct 2009

Health reform a chance for mental health care changes

The Baltimore Sun reports that congressional efforts to reform the health care system could lead to improvements in care for the nation's mentally ill.

5 Oct 2009

Supportive housing program is cost-effective option for people with mental illness

In the wake of a landmark decision by Federal District Judge Nicholas Garaufis, who in early September ruled that New York State is violating the Americans with Disabilities Act by segregating individuals with mental illness from the general population and fostering "learned helplessness," detrimental to rehabilitation and recovery, Community Access is inviting neighbors, local businesses and friends to tour its supportive housing sites in New York City this October

5 Oct 2009

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.

5 Oct 2009

Study shows that GSK-3 gene determines the total number of neurons required for brain

In populating the growing brain, neural stem cells must strike a delicate balance between two key processes - proliferation, in which the cells multiply to provide plenty of starting materials - and differentiation, in which those materials evolve into functioning neurons.

5 Oct 2009

Study finds that visual impairment in T1D patients may be decreasing

People diagnosed with type 1 diabetes (T1D) in recent years are less likely to develop diabetes-related vision loss than those diagnosed in earlier years, says a new study funded by the National Eye Institute, a division of the National Institutes of Health. Forecasts of visual impairment prevalence in T1D patients may need to be amended, the researchers suggest, since current predictions assume that the earlier incidence rates will continue.

3 Oct 2009

Clinical scientists call for a reform in clinical psychology training programs

The prevalence of mental health disorders in this country has nearly doubled in the past 20 years. Who is treating all of these patients? Clinical psychologists and therapists are charged with the task, but many are falling short by using methods that are out of date and lack scientific rigor. This is in part because many of the training programs-especially some Doctorate of Psychology (PsyD) programs and for-profit training centers-are not grounded in science.

3 Oct 2009

University of Florida to study whether exercise can prevent disability in older people

The University of Florida will receive $29.5 million in federal stimulus funds over the next two years from the National Institute on Aging to begin a six-year study on whether a program of structured physical activity can prevent or delay major movement disability in older adults.

3 Oct 2009

Opening Minds launched to reduce stigma of mental illness

Opening Minds, the largest systematic effort in Canadian history to reduce the stigma of mental illness, was launched today by the Honourable Michael Kirby, Chair of the Mental Health Commission of Canada. "More than seven million Canadians will experience a mental health problem in 2009. Many of these people will not seek help because of the stigma surrounding mental illness. In fact, people who live with mental illness tell us that the stigma is often worse than the disease itself", says Kirby.

3 Oct 2009

Mental Health News and Research

Latest Mental Health News and Research

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Cognitive behavioral therapy effective for bulimia and binge eating disorders

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

Telephone program to mange depression offers significant benefits at moderate increase in costs: Study

Individuals who follow the Mediterranean dietary pattern at reduced risk to develop depression: Study

Group Health Research Institute to receive federal stimulus funds from ARRA

NIH awards Galenea a Challenge Grant for developing predictive in vivo models of cognition

Depression leads to elevated inflammatory proteins in the human body: Study

Pico-Tesla commences Phase III clinical trial its Resonator system for treating Parkinson’s disease

Butler Hospital leads clinical study for effectiveness and safety of DBS for OCD

Health reform a chance for mental health care changes

Supportive housing program is cost-effective option for people with mental illness

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

Study shows that GSK-3 gene determines the total number of neurons required for brain

Study finds that visual impairment in T1D patients may be decreasing

Clinical scientists call for a reform in clinical psychology training programs

University of Florida to study whether exercise can prevent disability in older people

Opening Minds launched to reduce stigma of mental illness

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Mental Health News and Research

Latest Mental Health News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in